NEUROPACE, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.62 USD | +1.72% |
|
-3.29% | +31.33% |
| 03-15 | North American Morning Briefing : Inflation -2- | DJ |
| 03-14 | Wells Fargo Upgrades NeuroPace to Overweight From Equalweight, Raises Price Target to $20 From $16 | MT |
Chart calendar NeuroPace, Inc.
122b18161f8028de0504b67b2.-GVhQ2YOM0S7ZAS3--q_cQ2zPB88OpAffD-eJDJfUzk.jSc4cCB_Zj3cMmn1go_3IGnSXVILF8BeGGurEkU0ZHGPAAg2PD9KPIgLVQ~40a12b14d37cf57c11ada85b43cd72d9
Upcoming events on NeuroPace, Inc.
Past events on NeuroPace, Inc.
| 08/04/2024 20:45 | Needham Healthcare Conference |
| 05/03/2024 21:30 | Q4 2023 Earnings Call |
| 05/03/2024 21:05 | Q4 2023 Earnings Release |
| 11/01/2024 15:30 | JPMorgan Healthcare Conference |
| 02/12/2023 20:00 | American Epilepsy Society Meeting - Exploiting the iEEG |
| 02/12/2023 19:30 | American Epilepsy Society Meeting - Applying Responsive Neuromodulation for Generalized Epilepsies |
| 01/12/2023 23:30 | American Epilepsy Society Meeting - Practical Advice for Building an Advanced Neuromodulation Practi |
| 28/11/2023 19:30 | Piper Sandler Healthcare Conference |
| 06/11/2023 21:30 | Q3 2023 Earnings Call |
| 06/11/2023 21:03 | Q3 2023 Earnings Release |
| 28/09/2023 18:15 | Cantor Global Healthcare Conference |
| 13/09/2023 | Lake Street Capital Markets Big7 Conference |
| 13/09/2023 14:30 | Morgan Stanley Global Healthcare Conference |
| 06/09/2023 | Wells Fargo Healthcare Conference |
| 08/08/2023 21:30 | Q2 2023 Earnings Call |
| 08/08/2023 21:03 | Q2 2023 Earnings Release |
| 07/06/2023 18:30 | Annual General Meeting |
| 04/05/2023 21:30 | Q1 2023 Earnings Call |
| 04/05/2023 21:05 | Q1 2023 Earnings Release |
| 17/04/2023 15:15 | Needham Healthcare Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 41,1 | 45,2 45,1 0.11% | 45,5 45,5 0.02% | 65,4 65,1 0.54% | 75,2 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -23,4 -20,2 -16.13% | -32,2 -37,0 13.15% | -17,4 -23,4 25.3% | -20,5 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -23,7 -21,0 -13.09% | -40,8 -41,7 2.08% | -27,2 -29,2 6.9% | -27,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -36,1 -34,0 -6.12% | -47,1 -48,3 2.59% | -33,0 -34,8 5.37% | -32,1 |
|
Net income Million USD | Released Forecast Spread | -24,3 | -36,1 -33,6 -7.44% | -47,1 -48,6 3.12% | -33,0 -34,9 5.49% | -32,2 |
|
EPS USD | Released Forecast Spread | -45,3 | -2,17 -1,81 -19.89% | -1,91 -1,96 2.75% | -1,27 -1,35 6.17% | -1,17 |
| Announcement Date | 24/03/21 | 10/03/22 | 02/03/23 | 05/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 11,0 11,0 -0.13% | 11,4 10,8 5.67% | 10,2 11,1 -7.94% | 11,2 10,0 11.57% | 12,8 12,8 -0.05% | 14,5 12,2 18.94% | 16,5 12,6 30.77% | 16,4 14,2 15.5% | 18,0 17,7 1.49% | 17,3 | 18,2 | 18,8 | 20,7 | 19,0 |
|
EBITDA Million USD | Released Forecast Spread | -8,94 -5,23 -70.91% | -8,19 -6,54 -25.25% | -8,30 -8,30 -0.03% | -7,96 -10,0 20.43% | -7,73 -8,73 11.5% | -6,15 -8,37 26.54% | -5,15 -9,20 44.01% | -3,49 -7,57 53.84% | -2,65 -5,10 47.96% | -5,73 | -5,00 | -4,67 | -4,17 | -7,00 |
|
EBIT Million USD | Released Forecast Spread | -9,02 -6,14 -46.72% | -9,76 -8,67 -12.63% | -11,0 -9,48 -15.7% | -10,2 -11,5 11.66% | -9,86 -10,6 7.41% | -8,32 -9,92 16.17% | -7,85 -10,4 24.39% | -5,95 -9,12 34.76% | -5,05 -6,94 27.24% | -7,91 | -7,19 | -6,54 | -5,50 | -7,00 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,7 -8,00 -33.66% | -11,5 -12,0 4.49% | -12,7 -11,0 -15.36% | -11,8 -13,0 9.35% | -11,1 -12,4 9.87% | -10,4 -10,9 4.52% | -9,12 -12,0 24.18% | -7,26 -10,4 30.22% | -6,20 -7,93 21.77% | -8,90 | -8,33 | -7,85 | -7,03 | -8,00 |
|
Net income Million USD | Released Forecast Spread | -10,7 -7,99 -33.85% | -11,5 -10,6 -8.63% | -12,7 -11,1 -14.38% | -11,8 -13,1 9.96% | -11,1 -12,4 10.43% | -10,4 -10,9 4.89% | -9,12 -11,8 22.55% | -7,26 -10,5 30.96% | -6,20 -8,09 23.36% | -8,90 | -8,45 | -7,77 | -7,12 | -8,00 |
|
EPS USD | Released Forecast Spread | -0,44 -0,33 -32% | -0,47 -0,43 -8.68% | -0,52 -0,45 -14.46% | -0,48 -0,54 10.78% | -0,45 -0,50 9.55% | -0,41 -0,45 7.87% | -0,36 -0,47 22.73% | -0,28 -0,41 31.45% | -0,23 -0,31 25.19% | -0,32 | -0,30 | -0,28 | -0,26 | -0,33 |
| Announcement Date | 10/03/22 | 12/05/22 | 11/08/22 | 08/11/22 | 02/03/23 | 04/05/23 | 08/08/23 | 06/11/23 | 05/03/24 | - | - | - | - | - |
| 30/04/2024 11:20 | GE HEALTHCARE TECHNOLOGIES INC.: Q1 2024 Earnings Release |
| 30/04/2024 21:05 | TRANSMEDICS GROUP, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | INMODE LTD.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BRUKER CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | HOLOGIC, INC.: Q2 2024 Earnings Release |
| 02/05/2024 21:05 | LEMAITRE VASCULAR, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | ILLUMINA, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | QUANTERIX CORPORATION: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 06:00 | SIEMENS HEALTHINEERS AG: Q2 2024 Earnings Release |
| 07/05/2024 11:50 | WATERS CORPORATION: Q1 2024 Earnings Release |
Past sector events for NeuroPace, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NPCE Stock
- Calendar NeuroPace, Inc.
